Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 3Wilms Tumor 1Sarcoma 1Rhabdoid Tumor 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Medulloblastoma 1Glioma 1Ganglioneuroblastoma 1Ependymoma 1Choroid Plexus Carcinoma 1Brain Neoplasms 1

Interventions

Cyclophosphamide 14Etoposide 12Temozolomide 10Carboplatin 9Granulocyte Colony-Stimulating Factor 8Filgrastim 8Vincristine 7etoposide phosphate 6X-Rays 6Thiotepa 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Cisplatin 6Topotecan 5Specimen Handling 5Radiotherapy 5Nuclear Medicine Department, Hospital 5Methotrexate 5fludarabine 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Mesna 4Melphalan 4Biopsy 4palbociclib 3Sirolimus 3Irinotecan 3Ifosfamide 3Busulfan 3Automobiles 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × Hematopoietic Stem Cell Transplantation × CNS × Clear all
NCT04521946 2024-10-26

Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

M.D. Anderson Cancer Center

Phase 1 Withdrawn
CNS

Choroid Plexus Carcinoma, Brain Neoplasms, Ependymoma, Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡